← Back to headlines



Medtronic Highlights Affera Momentum and FDA Breakthrough Designation
Medtronic (MDT) emphasized the strong momentum of its Affera platform and its recent FDA Breakthrough Device Designation, signaling advancements in its medical technology.
5 May, 11:39 — 5 May, 11:39
Sources
Showing 1 of 1 sources
Related Stories
UAE Launches National Program to Advance Scientific and Technological Expertise
1h ago

Bill Gates Warns of Turbulent New Era Driven by Artificial Intelligence
2h ago

Apple Confirms September 9 Launch for iPhone 18 Series
9h ago
Meta’s Multi-Billion Dollar Child Safety Settlement Sets New Tech Regulation Precedent
16h ago